Cheryl McDonald

2.7k total citations
27 papers, 769 citations indexed

About

Cheryl McDonald is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Cheryl McDonald has authored 27 papers receiving a total of 769 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Infectious Diseases, 15 papers in Virology and 9 papers in Emergency Medicine. Recurrent topics in Cheryl McDonald's work include HIV/AIDS drug development and treatment (22 papers), HIV Research and Treatment (15 papers) and HIV/AIDS Research and Interventions (11 papers). Cheryl McDonald is often cited by papers focused on HIV/AIDS drug development and treatment (22 papers), HIV Research and Treatment (15 papers) and HIV/AIDS Research and Interventions (11 papers). Cheryl McDonald collaborates with scholars based in United States, United Kingdom and France. Cheryl McDonald's co-authors include Moti Ramgopal, Andrew Cheng, Moupali Das, Christian Callebaut, Scott McCallister, Judith M. Stern, Edwin DeJesus, Gordon Crofoot, Brian L. Robbins and Arnold Fridland and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Clinical Endocrinology & Metabolism and Clinical Infectious Diseases.

In The Last Decade

Cheryl McDonald

26 papers receiving 751 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cheryl McDonald United States	14	619	431	212	154	102	27	769
Antoni Jou Spain	15	543 0.9×	484 1.1×	232 1.1×	339 2.2×	105 1.0×	23	904
Manuela Colafigli Italy	21	721 1.2×	685 1.6×	347 1.6×	287 1.9×	38 0.4×	63	1.1k
Maria Martínez‐Rebollar Spain	13	507 0.8×	275 0.6×	168 0.8×	233 1.5×	173 1.7×	49	684
Krischan J Hudson United States	11	535 0.9×	358 0.8×	84 0.4×	214 1.4×	28 0.3×	17	698
Jesús Troya Spain	14	445 0.7×	189 0.4×	79 0.4×	302 2.0×	158 1.5×	50	741
Michael Aboud United Kingdom	13	950 1.5×	703 1.6×	407 1.9×	172 1.1×	55 0.5×	31	1.1k
Arturo Ciccullo Italy	13	430 0.7×	307 0.7×	148 0.7×	126 0.8×	29 0.3×	70	510
Hal Martin United States	21	1.6k 2.7×	1.2k 2.7×	838 4.0×	252 1.6×	135 1.3×	44	1.8k
Letty Mintz United States	5	376 0.6×	257 0.6×	120 0.6×	197 1.3×	24 0.2×	6	532
Francesca Lombardi Italy	14	356 0.6×	243 0.6×	124 0.6×	130 0.8×	22 0.2×	72	563

Countries citing papers authored by Cheryl McDonald

Since Specialization

Citations

This map shows the geographic impact of Cheryl McDonald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheryl McDonald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheryl McDonald more than expected).

Fields of papers citing papers by Cheryl McDonald

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheryl McDonald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheryl McDonald. The network helps show where Cheryl McDonald may publish in the future.

Co-authorship network of co-authors of Cheryl McDonald

This figure shows the co-authorship network connecting the top 25 collaborators of Cheryl McDonald. A scholar is included among the top collaborators of Cheryl McDonald based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheryl McDonald. Cheryl McDonald is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hagins, Debbie, Mezgebe Berhe, Gordon Crofoot, et al.. (2025). Final efficacy and safety of twice-yearly subcutaneous lenacapavir in treatment-naive people with HIV. AIDS. 40(3). 302–311.

Gupta, Samir K., Mezgebe Berhe, Gordon Crofoot, et al.. (2022). Lenacapavir administered every 26 weeks or daily in combination with oral daily antiretroviral therapy for initial treatment of HIV: a randomised, open-label, active-controlled, phase 2 trial. The Lancet HIV. 10(1). e15–e23. 65 indexed citations

Hagins, Debbie, Princy Kumar, Michael S. Saag, et al.. (2020). 1046. Week 48 Outcomes from the BRAAVE 2020 Study: A Randomized Switch to B/F/TAF in African American Adults with HIV. Open Forum Infectious Diseases. 7(Supplement_1). S552–S553. 1 indexed citations

Spinelli, Matthew A., Jennifer A. Shuford, Mary F. Kearney, et al.. (2020). Use of Drug-level Testing and Single-genome Sequencing to Unravel a Case of Human Immunodeficiency Virus Seroconversion on Pre-exposure Prophylaxis. Clinical Infectious Diseases. 72(11). 2025–2028. 4 indexed citations

Eron, Joseph J., Jean‐Daniel Lelièvre, Robert C. Kalayjian, et al.. (2018). Safety of elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in HIV-1-infected adults with end-stage renal disease on chronic haemodialysis: an open-label, single-arm, multicentre, phase 3b trial. The Lancet HIV. 6(1). e15–e24. 21 indexed citations

Spinner, Christoph D., Bruce Rashbaum, Cheryl McDonald, et al.. (2018). 541. Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in HIV-1 Treatment Naïve Patients: Week 48 Results in Subgroups Based on Baseline Viral Load, CD4+ Count, and WHO Clinical Staging. Open Forum Infectious Diseases. 5(suppl_1). S201–S201. 1 indexed citations

Luetkemeyer, Anne F., Cheryl McDonald, Moti Ramgopal, et al.. (2016). 12 Weeks of Daclatasvir in Combination With Sofosbuvir for HIV-HCV Coinfection (ALLY-2 Study): Efficacy and Safety by HIV Combination Antiretroviral Regimens. Clinical Infectious Diseases. 62(12). 1489–1496. 45 indexed citations

Mills, Anthony, Gordon Crofoot, Cheryl McDonald, et al.. (2015). Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate in the First Protease Inhibitor–Based Single-Tablet Regimen for Initial HIV-1 Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 69(4). 439–445. 121 indexed citations

Luetkemeyer, Annie, Cheryl McDonald, Moti Ramgopal, et al.. (2015). 12 Weeks of Daclatasvir in Combination With Sofosbuvir for HIV/HCV Coinfection (ALLY-2 Study): Efficacy and Safety by HIV Combination Antiretroviral Regimens. Open Forum Infectious Diseases. 2(suppl_1). 1 indexed citations

10.

Thompson, Melanie, Javier O Morales-Ramirez, Cheryl McDonald, et al.. (2015). Switching from a Tenofovir Disoproxil Fumarate (TDF) to a Tenofovir Alafenamide (TAF)-Based Single Tablet Regimen (STR): Week 48 Data in HIV-1-Infected Virologically Suppressed Adults. Open Forum Infectious Diseases. 2(suppl_1). 1 indexed citations

11.

Fisher, Martin, Cheryl McDonald, Graeme Moyle, et al.. (2014). Switching from ritonavir to cobicistat in HIV patients with renal impairment who are virologically suppressed on a protease inhibitor. Journal of the International AIDS Society. 17(4S3). 19824–19824. 9 indexed citations

12.

McDonald, Cheryl, Claudia Martorell, Moti Ramgopal, et al.. (2014). Cobicistat-Boosted Protease Inhibitors in HIV-Infected Patients with Mild to Moderate Renal Impairment. HIV Clinical Trials. 15(6). 269–273. 12 indexed citations

13.

McDonald, Cheryl, Jonathan Uy, Wenhua Hu, et al.. (2012). Clinical Significance of Hyperbilirubinemia Among HIV-1–Infected Patients Treated with Atazanavir/Ritonavir Through 96 Weeks in the CASTLE Study. AIDS Patient Care and STDs. 26(5). 259–264. 25 indexed citations

14.

Kozal, Michael J., Sergio Lupo, Edwin DeJesus, et al.. (2012). A Nucleoside- and Ritonavir-Sparing Regimen Containing Atazanavir Plus Raltegravir in Antiretroviral Treatment-Naïve HIV-Infected Patients: SPARTAN Study Results. HIV Clinical Trials. 13(3). 119–130. 70 indexed citations

15.

DeJesus, Edwin, Peter Ruane, Cheryl McDonald, et al.. (2008). Impact of Switching Virologically Suppressed, HIV-1-Infected Patients from Twice-Daily Fixed-Dose Zidovudine/Lamivudine to Once-Daily Fixed-Dose Tenofovir Disoproxil Fumarate/Emtricitabine. HIV Clinical Trials. 9(2). 103–114. 27 indexed citations

16.

Benson, Constance A., Charles van der Horst, Anthony LaMarca, et al.. (2004). A randomized study of emtricitabine and lamivudine in stably suppressed patients with HIV. AIDS. 18(17). 2269–2276. 42 indexed citations

17.

McDonald, Cheryl, Andrea Dunaif, & Diane T. Finegood. (2000). Minimal-Model Estimates of Insulin Sensitivity Are Insensitive to Errors in Glucose Effectiveness¹. The Journal of Clinical Endocrinology & Metabolism. 85(7). 2504–2508. 18 indexed citations

18.

Robbins, Brian L., Jack Rodman, Cheryl McDonald, et al.. (1994). Enzymatic assay for measurement of zidovudine triphosphate in peripheral blood mononuclear cells. Antimicrobial Agents and Chemotherapy. 38(1). 115–121. 59 indexed citations

19.

McDonald, Cheryl, et al.. (1993). Neutrophilic CSF Pleocytosis in Hypertensive Encephalopathy. The American Journal of the Medical Sciences. 306(3). 167–168. 3 indexed citations

20.

Stern, Judith M. & Cheryl McDonald. (1989). Ovarian hormone-induced short-latency maternal behavior in ovariectomized virgin Long-Evans rats. Hormones and Behavior. 23(2). 157–172. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact